People · Operator
Named in public records as an officer, director or promoter · active 2013–2016 · Healthtech, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Monteris Medical US, Inc. | — | Healthtech | Series B | $82.5M | $168.0M | 2014 |
| Monteris Medical Inc | — | Biotechnology | Seed | $9.0M | $163.1M | 2013 |
Daniel Cole at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Daniel Cole on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Patrick Morand | 2 | 5 |
| Gregory Barrett | 2 | 4 |
| John Schellhorn | 2 | 4 |
| James Richardson | 2 | 4 |
| Gary Bantle | 2 | 2 |
| Kevin McGarry | 2 | 2 |
| Robert K Davidson | 2 | 2 |
| Kirk Nielsen | 1 | 13 |
| Matthew Strobeck | 1 | 3 |
| James Reinstein | 1 | 3 |
| Joseph Biller | 1 | 3 |
| Richard Emmitt | 1 | 3 |
| Joe Biller | 1 | 3 |
| James Erickson | 1 | 2 |
| Martin Emerson | 1 | 2 |
| Jim Duncan | 1 | 1 |
| Jim Richmond | 1 | 1 |
| Bill Hoffman | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.